# $HYPERLIQUID Social Sentiment & Intelligence — 2026-08-19 08:10 UTC

> **Asset:** $HYPERLIQUID  
> **Momentum Status:** Trending Up  
> **Timestamp:** 2026-08-19 08:10 UTC (2026-08-19T08:10:00Z)  
> **Canonical URL:** https://cryptitalk.com/2026-08-19-08-10/crypto/HYPERLIQUID  
> **Overview Brief:** https://cryptitalk.com/2026-08-19-08-10/crypto.md  

---

## 10-Minute Social Metrics
- **Posts Analyzed:** 1
- **Total Impressions:** 135
- **Likes:** 14
- **Retweets:** 0
- **Comments:** 9

---


## Momentum & Sentiment Analysis
Total Engagement - Comments: 9, Retweets: 0, Likes: 14, Impressions: 135


---

## Cited Community Posts & Evidence


### Post #1 by @Ten_Gildong
> **Author:** [@Ten_Gildong](https://x.com/Ten_Gildong)  
> **Metrics:** 6 likes · 0 retweets · 1 comments · 286 views  


> **Source Link:** [https://x.com/Ten_Gildong/status/2089891228427178113](https://x.com/Ten_Gildong/status/2089891228427178113)  


> **Visual Context:** LinkedIn post by Adrian Brückner, Team Lead at eXoZymes Inc., celebrating an NCT process development milestone and highlighting team contributions with hashtags #Biomanufacturing #Biotechnology #Nutraceuticals #ProcessDevelopment #eXoZymes.  

> 
> "금일 
$EXOZ
 제조역량 소식이 발표된 후,, 팀 내 반응

“바이오제조의 미래는 무세포(cell-free)입니다. 그리고 그 미래는 밝습니다!”

그렇다면 우리가 캘리포니아에서 계속 다루고 실험해온 이 효소 기술, 도대체 언제부터 정말 ‘현실적인 것’이 되는 걸까요?

음, 이 기술을 실제로 사용하고 싶어"




---


## Contributing Accounts

- `@nicksolrik` (https://x.com/nicksolrik)